Effect of hypertension and hypertrophy on coronary microvascular pressure

M Fujii1, D W Nuno, K G Lamping

  • 1Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City 52242.

Insights

Hypertension and left ventricular hypertrophy increase coronary microvascular pressure differences. This heightened transmural resistance in the endocardium may increase the risk of subendocardial ischemia in these patients.

Area of Science:

  • Cardiovascular Physiology
  • Renal Hypertension Research

Background:

  • Coronary microvascular pressure transmural differences are crucial for myocardial perfusion.
  • Hypertension and left ventricular hypertrophy are known risk factors for cardiovascular disease.

Purpose of the Study:

  • To investigate if transmural differences in coronary microvascular pressures are amplified in the presence of hypertension and left ventricular hypertrophy.
  • To determine the impact of hypertension and hypertrophy on coronary microvascular resistance.

Main Methods:

  • Isolated, arrested canine hearts underwent adenosine vasodilation.
  • Epicardial and endocardial microvascular pressures were measured at varying left main coronary perfusion pressures (60-100 mm Hg).
  • Comparisons were made between normotensive and hypertensive (one-clip, one-kidney) groups.

Main Results:

  • Endocardial microvascular pressures were consistently lower than epicardial pressures across all perfusion levels in both groups.
  • Epicardial arteriole pressures, as a percentage of perfusion pressure, were similar between normotensive and hypertensive hearts.
  • Endocardial pressures at 90 and 100 mm Hg perfusion were significantly lower in hypertensive, hypertrophied hearts compared to controls.

Conclusions:

  • Hearts with hypertension and hypertrophy exhibit greater transmural resistance to microvascular perfusion.
  • Altered vascular anatomy secondary to hypertension and hypertrophy likely contributes to this resistance.
  • Increased endocardial resistance may predispose to subendocardial ischemia in hypertensive, hypertrophied hearts.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...